Compound ID | 3405
LMN-201
Synonym(s): LMN 201 | LMN201 | LMN-Cdiff01
Class: Bacteriophage and phage-derived enzyme
| Agent Type: | Indirect acting; Bacteriophage or bacteriphage-derived product; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Antibody-like proteins neutralize bacterial toxin whilst enzyme-protein targets Clostridium difficile cell wall |
| Target Pathogen: | Active against Clostridioides difficile; indicated for recurrent C. difficile infection |
| Description: | Contains antibody-like proteins and cell-wall degrading enzyme |
| Institute where first reported: | Lumen Bioscience |
| Year first mentioned: | 2022 |
| Highest development stage: | Phase 3 |
| Development status: | Active |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.